Different molecular pathways are disrupted in Pyoderma gangrenosum patients and are associated with the severity of the disease

Abstract

Pyoderma gangrenosum (PG) is a rare inflammatory skin disease classified within the spectrum of neutrophilic dermatoses. The pathophysiology of PG is yet incompletely understood but a prominent role of genetics facilitating immune dysregulation has been proposed. This study investigated the potential contribution of disrupted molecular pathways in determining the susceptibility and clinical severity of PG. Variant Enrichment Analysis, a bioinformatic pipeline applicable for Whole Exome Sequencing data was performed in unrelated PG patients. Eleven patients were enrolled, including 5 with unilesional and 6 with multilesional PG. Fourteen pathways were exclusively enriched in the "multilesional" group, mainly related to immune system (i.e., type I interferon signaling pathway), cell metabolism and structural functions. In the "unilesional" group, nine pathways were found to be exclusively enriched, mostly related to cell signaling and cell metabolism. Genetically altered pathways involved in immune system biology and wound repair appear to be nodal pathogenic drivers in PG pathogenesis.

Figure 1

Veen diagram analysis of Variant Enrichment Analysis (VEA) of 11 exomes from patients with Pyoderma gangrenosum classified by disorder’s severity. 8 enriched pathways (EP) are shared between “unilesional” and multilesional. 9 and 14 EP exclusive in “unilesional” and multilesional respective.